I have never thought Diagnostics Phase 3 applications would Qualify for FDA, Fast Track Designation Status, but I think this could be the exception and look forward to getting other opinions.
It meets unmet medical need (there are chronic shortages of current standard care drugs currently used)
It has preliminary clinical evidence that it provides a meaningful improvement in diagnosis (believe the last trial show this)
Saves Lives , early accurate detection saves lives.
Interested in other opinions.
Arthur
- Forums
- ASX - By Stock
- Ann: PROPELLER Trial Results
I have never thought Diagnostics Phase 3 applications would...
Featured News
Add CU6 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.09 |
Change
0.000(0.00%) |
Mkt cap ! $1.272B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5360 | $4.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.08 | 1846 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5360 | 4.410 |
1 | 1000 | 4.320 |
2 | 2431 | 4.250 |
2 | 196 | 4.150 |
3 | 2375 | 4.120 |
Price($) | Vol. | No. |
---|---|---|
4.080 | 1846 | 1 |
4.090 | 120 | 1 |
4.100 | 5378 | 1 |
4.160 | 5000 | 1 |
4.170 | 15000 | 1 |
Last trade - 09.50am 22/05/2024 (20 minute delay) ? |
|
|||||
Last
$4.12 |
  |
Change
0.000 ( 0.60 %) |
|||
Open | High | Low | Volume | ||
$4.12 | $4.12 | $4.12 | 56 | ||
Last updated 10.10am 22/05/2024 ? |
Featured News
CU6 (ASX) Chart |
Day chart unavailable
The Watchlist
AUQ
ALARA RESOURCES LIMITED
Stephen Gethin, Non-Executive Director & Chairman
Stephen Gethin
Non-Executive Director & Chairman
Previous Video
Next Video
SPONSORED BY The Market Online